GL1X · GenesisL1 explorer

MolNFT v1 · #90021 · protein

JAK2 kinase (JH1 domain) triple mutant in complex with compound 12

4E6Q · Tyrosine-protein kinase JAK2: “JAK2 kinase (JH1 domain) triple mutant in complex with compound 12”. X-ray diffraction, 1 ligand (0NV), 6 pockets (best druggability 0.73). MolNFT v1 #90021 on GenesisL1: 3D structure, binding sites…

PDB
4E6Q
Type
protein
Length
596 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK2
EC
2.7.10.2
UniProt
O60674
Ligands
0NV
Pockets
6 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BTyrosine-protein kinase JAK2 (EC 2.7.10.2)protein29842% helix, 18% strandO60674

Ligands and binding sites

  • 0NV · 1-(1-benzylpiperidin-4-yl)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17410.730.79720NV
25810.730.80550NV
31610.580.8220empty
4940.350.7418empty
5600.310.7513empty

Interfaces

1 interface between chains.

  • A–B · 715 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (phosphorylation).

Compared structures

  • 4E6Q · JAK2 kinase (JH1 domain) triple mutant in complex with compound 12 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.